269 related articles for article (PubMed ID: 20711703)
1. The case for complement and inflammation in AMD: open questions.
Karagianni N; Adamis AP
Adv Exp Med Biol; 2010; 703():1-7. PubMed ID: 20711703
[TBL] [Abstract][Full Text] [Related]
2. Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration.
Rohrer B
Adv Exp Med Biol; 2018; 1074():45-51. PubMed ID: 29721926
[TBL] [Abstract][Full Text] [Related]
3. Complement System and Potential Therapeutics in Age-Related Macular Degeneration.
Park YG; Park YS; Kim IB
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202223
[TBL] [Abstract][Full Text] [Related]
4. Drusen complement components C3a and C5a promote choroidal neovascularization.
Nozaki M; Raisler BJ; Sakurai E; Sarma JV; Barnum SR; Lambris JD; Chen Y; Zhang K; Ambati BK; Baffi JZ; Ambati J
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2328-33. PubMed ID: 16452172
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of the complement system in age-related macular degeneration: a review.
Troutbeck R; Al-Qureshi S; Guymer RH
Clin Exp Ophthalmol; 2012; 40(1):18-26. PubMed ID: 22304025
[TBL] [Abstract][Full Text] [Related]
6. Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option.
Qin S; Dong N; Yang M; Wang J; Feng X; Wang Y
J Immunol Res; 2021; 2021():9945725. PubMed ID: 34368372
[TBL] [Abstract][Full Text] [Related]
7. Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration.
Ebrahimi KB; Fijalkowski N; Cano M; Handa JT
J Pathol; 2013 Apr; 229(5):729-42. PubMed ID: 23097248
[TBL] [Abstract][Full Text] [Related]
8. Genetic control of complement activation in humans and age related macular degeneration.
Hecker LA; Edwards AO
Adv Exp Med Biol; 2010; 703():49-62. PubMed ID: 20711706
[TBL] [Abstract][Full Text] [Related]
9. Dry age-related macular degeneration: recent progress of therapeutic approaches.
Kuno N; Fujii S
Curr Mol Pharmacol; 2011 Nov; 4(3):196-232. PubMed ID: 21545354
[TBL] [Abstract][Full Text] [Related]
10. Age related macular degeneration and drusen: neuroinflammation in the retina.
Buschini E; Piras A; Nuzzi R; Vercelli A
Prog Neurobiol; 2011 Sep; 95(1):14-25. PubMed ID: 21740956
[TBL] [Abstract][Full Text] [Related]
11. AMD--the retinal disease with an unprecised etiopathogenesis: in search of effective therapeutics.
Nowak JZ
Acta Pol Pharm; 2014; 71(6):900-16. PubMed ID: 25745762
[TBL] [Abstract][Full Text] [Related]
12. RPE cell senescence: a key contributor to age-related macular degeneration.
Kozlowski MR
Med Hypotheses; 2012 Apr; 78(4):505-10. PubMed ID: 22296808
[TBL] [Abstract][Full Text] [Related]
13. THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.
Boyer DS; Schmidt-Erfurth U; van Lookeren Campagne M; Henry EC; Brittain C
Retina; 2017 May; 37(5):819-835. PubMed ID: 27902638
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms of Complement System Proteins and Matrix Metalloproteinases in the Pathogenesis of Age-Related Macular Degeneration.
Mansoor N; Wahid F; Azam M; Shah K; den Hollander AI; Qamar R; Ayub H
Curr Mol Med; 2019; 19(10):705-718. PubMed ID: 31456517
[TBL] [Abstract][Full Text] [Related]
15. The complement regulatory protein CD59: insights into attenuation of choroidal neovascularization.
Schnabolk G; Tomlinson S; Rohrer B
Adv Exp Med Biol; 2014; 801():435-40. PubMed ID: 24664728
[TBL] [Abstract][Full Text] [Related]
16. Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.
Toomey CB; Landowski M; Klingeborn M; Kelly U; Deans J; Dong H; Harrabi O; Van Blarcom T; Yeung YA; Grishanin R; Lin JC; Saban DR; Bowes Rickman C
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):662-673. PubMed ID: 29392311
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the complement system, risk factors and prediction models in age-related macular degeneration.
Bora NS; Matta B; Lyzogubov VV; Bora PS
Mol Immunol; 2015 Feb; 63(2):176-83. PubMed ID: 25074023
[TBL] [Abstract][Full Text] [Related]
18. A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration.
Rohrer B; Long Q; Coughlin B; Renner B; Huang Y; Kunchithapautham K; Ferreira VP; Pangburn MK; Gilkeson GS; Thurman JM; Tomlinson S; Holers VM
Adv Exp Med Biol; 2010; 703():137-49. PubMed ID: 20711712
[TBL] [Abstract][Full Text] [Related]
19. Complement cascade inhibition in geographic atrophy: a review.
Desai D; Dugel PU
Eye (Lond); 2022 Feb; 36(2):294-302. PubMed ID: 34999723
[TBL] [Abstract][Full Text] [Related]
20. The complement system and age-related macular degeneration.
Sivaprasad S; Chong NV
Eye (Lond); 2006 Aug; 20(8):867-72. PubMed ID: 16410816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
